Trials / Terminated
TerminatedNCT04654325
Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 534 (actual)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the prevalence of SARS-CoV-2 genome in patients with asymptomatic and moderately symptomatic COVID19.
Detailed description
Patients attending to the COVID19 screening facility of Paris South University hospital and willing to participate to the study will have both nasopharyngeal and conjunctival swab for SARS-CV-2 genome detection using PCR. The project will evaluate the prevalence of positive conjunctival swabs in patients with positive nasopharyngeal swab. These results will be corelated to symptoms of disease assessed with a standardized questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | conjunctival swab | Patients will have conjunctival swab for SARS-CV-2 genome detection |
Timeline
- Start date
- 2021-01-19
- Primary completion
- 2021-04-29
- Completion
- 2021-04-29
- First posted
- 2020-12-04
- Last updated
- 2022-09-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04654325. Inclusion in this directory is not an endorsement.